We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dopaminergic D<sub>1</sub> and D<sub>2</sub> Receptors Are Essential for the Arousal Effect of Modafinil.
- Authors
Wei-Min Qu; Zhi-Li Huang; Xin-Hong Xu; Matsumoto, Naomi; Urade, Yoshihiro
- Abstract
Modafinil is a wake-promoting compound with low abuse potential used in the treatment of narcolepsy. Although the compound is reported to affect multiple neurotransmitter systems such as catecholamines, serotonin, glutamate, GABA, orexin, and histamine, however, the molecular mechanism by which modafinil increases wakefulness is debated. Herein we used dopamine (DA) D2 receptor (D2R)-deficient mice combined with D1R- and D2R-specific antagonists to clarify the role of DA receptors in the arousal effects of modafinil. In wild-type mice, intraperitoneal modafinil induced wakefulness in a dose-dependent manner. Pretreatment with eitherD1R antagonist SCH23390 [R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine] at 30 μg/kg or D2R antagonist raclopride at 2 mg/kg blocked the arousal effects of low-dose modafinil at 22.5 and 45 mg/kg. When modafinil was given at 90 and 180 mg/kg, pretreatment of D1R antagonist did not affect the wakefulness at all, whereas D2R antagonist significantly attenuated the wakefulness to the half level compared with vehicle control. Similarly,D2R knock-out (KO) mice exhibited attenuated modafinil-induced wakefulness. However, pretreatment of D2R KO mice with D1R antagonist completely abolished arousal effects of modafinil. These findings strongly indicate that dopaminergic D1R and D2R are essential for the wakefulness induced by modafinil.
- Subjects
NEUROSCIENCES; DOPAMINE receptors; NEUROTRANSMITTERS; SEROTONIN; GLUTAMIC acid; SLEEP-wake cycle
- Publication
Journal of Neuroscience, 2008, Vol 28, Issue 34, p8462
- ISSN
0270-6474
- Publication type
Article
- DOI
10.1523/JNEUROSCI.1819-08.2008